News | June 08, 2023
Coveris opens new recover recycling facility with pioneering technology
The new recycling facility, Recover Louth, is the second addition to Coveris’ closed loop recycling business segment
The new recycling facility, Recover Louth, is the second addition to Coveris’ closed loop recycling business segment
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
Getinge has a strong market share in India within several product segments
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
This sBLA submission is supported by clinical, pre-clinical, and manufacturing data demonstrating the safety, tolerability, and immunogenicity of the bivalent vaccine.
Data build on previously reported results from the primary endpoint of investigator-assessed radiographic progression-free survival
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
Subscribe To Our Newsletter & Stay Updated
